Research about narcolepsy has been carried out for about 145-150 years, but it is only in the last 18-20 years that there has been advancement in the underlying pathophysiology, diagnosis, and, thus, availability of better treatment. Both pharmacological and non-pharmacological methods are ...
Liblau, RolandPeyron, ChristelleDauvilliers, YvesCNS DrugsCns DrugsBarateau L, Liblau R, Peyron C, et al. Narcolepsy type 1 as an autoimmune disorder: evidence, and implications for pharmacological treatment. CNS Drugs 2017; 31: 821-834....
Cognitive-Behavioural Therapy for Type 1 Narcolepsy Comorbid With Sleep and Psychiatric Disturbances: A Case Report There is currently a lack of clinical research that would strongly support the application of CBT in the treatment of narcolepsy type 1. Despite that, ther... I Zeevi - 《Behaviour...
Healthcare providers should collaborate closely with patients to develop a treatment plan that includes interventions intended to develop a broader and more effective repertoire of coping strategies. This recommendation is consistent with current guidelines for the management of narcolepsy that underscore the...
narcolepsydisrupted nighttime sleepsleep instabilitysleep qualityfatigueStudy Objectives:Disrupted nighttime sleep and sleep instability are common in children and adolescents with narcolepsy type 1, but optimal objective sleep measures have not been determined. We compared self-reported and objective sleep ...
Narcolepsy is a sparsely found disease with a prevalence of 0.02-0.07% worldwide. Most patients are diagnosed much later than symptom onset with a gap of several years to even decades. The inability to diagnose and lack of awareness of narcolepsy leads to poor quality of life for the patient...
Myotonic dystrophy type 1 is frequently associated with excessive daytime sleepiness, sharing with narcolepsy a short sleep latency and the presence of sleep-... Martínez-Rodríguez Jose E.,L Lin,I Alex,... - 《Sleep》 被引量: 127发表: 2003年 A polysomnographic study of daytime sleepiness...
Contradictory data on type 1 diabetes in a recently published article 'Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2years of follow-up' ( ...
While epilepsy was the primary concern of patients with LGI1, those with anti-Ma2 tended to experience additional neurological issues such as narcolepsy or behavioral changes. Cancerous tumors were detected in two of the three anti-Ma2 patients but none of the LGI1 patients. Both groups had...
learning disabilities. Cataplexy, with or without narcolepsy, typically laughter-induced, is another common symptom. Ataxia soon becomes obvious, with frequent falls and difficulties to run, and progresses at a variable rate. Dysarthria develops, as well as dysphagia. Action dystonia is also frequent...